NeuroBo Pharmaceuticals (NRBO) Competitors $0.64 +0.02 (+3.05%) As of 08/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NRBO vs. GREE, ARBK, BTCT, ANY, GLBZ, SAIH, NCPL, CARV, MIGI, and SLNHShould you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include Greenidge Generation (GREE), Argo Blockchain (ARBK), BTC Digital (BTCT), Sphere 3D (ANY), Glen Burnie Bancorp (GLBZ), SAIHEAT (SAIH), Netcapital (NCPL), Carver Bancorp (CARV), Mawson Infrastructure Group (MIGI), and Soluna (SLNH). These companies are all part of the "banking" industry. NeuroBo Pharmaceuticals vs. Its Competitors Greenidge Generation Argo Blockchain BTC Digital Sphere 3D Glen Burnie Bancorp SAIHEAT Netcapital Carver Bancorp Mawson Infrastructure Group Soluna Greenidge Generation (NASDAQ:GREE) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap banking companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability. Which has higher valuation & earnings, GREE or NRBO? NeuroBo Pharmaceuticals has lower revenue, but higher earnings than Greenidge Generation. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenidge Generation$59.53M0.36-$19.78MN/AN/ANeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A Which has more volatility & risk, GREE or NRBO? Greenidge Generation has a beta of 3.14, suggesting that its stock price is 214% more volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. Is GREE or NRBO more profitable? NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Greenidge Generation's net margin of -33.68%. Greenidge Generation's return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Greenidge Generation-33.68% N/A -34.08% NeuroBo Pharmaceuticals N/A -189.12%-122.31% Does the media favor GREE or NRBO? In the previous week, Greenidge Generation had 2 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 2 mentions for Greenidge Generation and 0 mentions for NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals' average media sentiment score of 0.00 beat Greenidge Generation's score of -0.29 indicating that NeuroBo Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Greenidge Generation Neutral NeuroBo Pharmaceuticals Neutral Do insiders & institutionals have more ownership in GREE or NRBO? 8.5% of Greenidge Generation shares are held by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. 27.8% of Greenidge Generation shares are held by company insiders. Comparatively, 1.1% of NeuroBo Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryGreenidge Generation beats NeuroBo Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get NeuroBo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRBO vs. The Competition Export to ExcelMetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.51M$834.68M$5.82B$9.74BDividend YieldN/A4.84%3.84%4.09%P/E RatioN/A1.1731.1525.97Price / SalesN/A26.53475.57123.18Price / CashN/A19.5637.1558.38Price / Book0.436.639.116.39Net Income-$12.47M-$4.94M$3.26B$265.66M7 Day Performance-0.16%0.95%2.11%1.98%1 Month Performance-6.04%2.99%5.12%1.33%1 Year Performance-82.49%11.85%31.25%21.15% NeuroBo Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRBONeuroBo PharmaceuticalsN/A$0.64+3.0%N/A-83.6%$5.51MN/A0.0010GREEGreenidge GenerationN/A$1.39-6.7%N/A-40.3%$21.46M$59.53M0.00680Gap DownARBKArgo Blockchain0.9389 of 5 stars$0.29-4.8%N/A-80.5%$20.54M$47.02M-0.2940News CoverageUpcoming EarningsShort Interest ↓BTCTBTC Digital1.1172 of 5 stars$2.49-3.5%N/A+48.7%$18.72M$11.68M0.0016Short Interest ↓Gap UpANYSphere 3D3.1264 of 5 stars$0.53-6.9%$3.00+469.9%-47.5%$14.91M$10.83M-0.8620GLBZGlen Burnie Bancorp1.7561 of 5 stars$4.00+1.0%N/A-17.9%$11.60M$11.62M400.4080Gap UpHigh Trading VolumeSAIHSAIHEATN/A$6.40-12.4%N/AN/A$11.20M$5.54M0.0037Positive NewsNCPLNetcapital0.073 of 5 stars$1.96-9.7%N/A-40.4%$9.25M$870K-0.09N/ACARVCarver Bancorp0.0944 of 5 stars$1.78+3.2%N/A-13.5%$9.02M$37.37M-0.73110Short Interest ↑Gap UpMIGIMawson Infrastructure Group0.5966 of 5 stars$0.42-6.7%N/A-72.5%$8.26M$59.26M-0.3240Negative NewsGap DownSLNHSoluna1.9173 of 5 stars$0.45-14.4%N/A-90.9%$8.11M$38.02M-0.0560Short Interest ↓Gap Down Related Companies and Tools Related Companies Greenidge Generation Alternatives Argo Blockchain Alternatives BTC Digital Alternatives Sphere 3D Alternatives Glen Burnie Bancorp Alternatives SAIHEAT Alternatives Netcapital Alternatives Carver Bancorp Alternatives Mawson Infrastructure Group Alternatives Soluna Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRBO) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access